CHU de Quebec Lands $10M to Test DNA, Serum-based Combo NIPT | GenomeWeb

NEW YORK (GenomeWeb News) – The Centre Hospitalier Universitaire de Quebec (CHUQ) has received C$10.5 million (US$10.1 million) in new funding from several Canadian government-affiliated groups to study the use of DNA sequencing coupled with a PerkinElmer serum test as a non-invasive technique for detecting birth defects, Genome Quebec said yesterday.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetic target for urothelial bladder cancer treatment, and more.

At the Conversation, the University of Oxford's Michael Macklay writes that learning genetic risk of disease is a personal decision.

Two dozen scientific organizations have endorsed the March for Science, according to ScienceInsider.

Researchers in Japan describe a chimpanzee with a chromosomal abnormality similar to human Down syndrome, Mashable reports.